Meeting
2021 ASCO Annual Meeting
The somatic mutation landscape of germline CHEK2-altered prostate cancer.
Authors
Emily Nizialek
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
Emily Nizialek , Tamara L. Lotan , William B. Isaacs , Srinivasan Yegnasubramanian , Channing Judith Paller , Emmanuel S. Antonarakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Other Prostate, Testicular, or Penile Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5084)
DOI
10.1200/JCO.2021.39.15_suppl.5084
Abstract #
5084
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Germline mutations in ATM, CHEK2, and other known/potential breast cancer susceptibility genes among BRCA-negative Uruguayan patients with breast cancer.
First Author: Lucia Beatriz Delgado
Poster
2022 ASCO Genitourinary Cancers Symposium
Germline BRCA2, ATM and CHEK2 alterations shape somatic mutation landscapes in prostate cancer.
First Author: Mari Nakazawa
Poster
2020 ASCO Virtual Scientific Program
Value of multigene panel retesting of families with BRCA1/2 mutation-negative hereditary breast and ovarian cancer (HBOC).
First Author: Ekaterina Meshoulam Nikolaeva
Poster
2018 ASCO Annual Meeting
DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.
First Author: Rahul Raj Aggarwal